QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
|
||
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Large accelerated filer |
☐ |
Accelerated filer |
☐ | |||
|
☒ |
Smaller reporting company |
| |||
Emerging growth company | |
Page | ||||
PART I. FINANCIAL INFORMATION |
||||
Item 1. |
3 | |||
4 | ||||
5 | ||||
6 | ||||
7 | ||||
10 | ||||
11 | ||||
Item 2. |
26 | |||
Item 3. |
42 | |||
Item 4. |
44 | |||
PART II. OTHER INFORMATION |
||||
Item 1. |
45 | |||
Item 1A. |
45 | |||
Item 2. |
93 | |||
Item 3. |
93 | |||
Item 4. |
93 | |||
Item 5. |
93 | |||
Item 6. |
9 4 |
ITEM 1. |
FINANCIAL STATEMENTS (UNAUDITED) |
As of September 30, |
As of December 31, |
|||||||
2021 |
2020 | |||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash |
||||||||
Accounts receivable |
||||||||
Marketable securities |
— |
|||||||
Prepaid expenses and other current assets |
||||||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Restricted cash, noncurrent |
||||||||
Operating lease right-of-use |
||||||||
Other assets |
||||||||
Total assets |
$ | |
$ | |
||||
Liabilities and Stockholders’ Equity |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued liabilities |
||||||||
Deferred revenue (1) |
||||||||
Customer deposits |
||||||||
Operating lease liabilities |
||||||||
Total current liabilities |
||||||||
Deferred revenue, noncurrent (1) |
||||||||
Customer deposits, noncurrent |
||||||||
Debt, noncurrent, net |
— | |||||||
Operating lease liabilities, noncurrent |
||||||||
Other noncurrent liabilities |
||||||||
Total liabilities |
||||||||
Commitments and Contingencies (Note 8) |
||||||||
Stockholders’ equity: |
||||||||
Preferred stock, par value $ |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive loss |
( |
( |
||||||
Accumulated deficit |
( |
( |
||||||
Total stockholders’ equity |
||||||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
(1) |
Deferred revenue as of September 30, 2021 and December 31, 2020 includes $ Note 6. Equity Method Investments |
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Revenue |
$ | $ | $ | $ | ||||||||||||
Cost of revenue |
||||||||||||||||
Gross profit |
||||||||||||||||
Operating expenses: |
||||||||||||||||
Sales and marketing |
||||||||||||||||
Research and development |
||||||||||||||||
General and administrative |
||||||||||||||||
Total operating expenses |
||||||||||||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Interest income |
||||||||||||||||
Interest expense |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Change in fair value of warrants |
— | ( |
) | — | ||||||||||||
Other income (expense), net |
( |
) | ( |
) | ( |
) | ||||||||||
Loss before provision (benefit) for income taxes |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Provision (benefit) for income taxes |
( |
) | ( |
) | ( |
) | ||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Net loss per share attributable to common stockholders, basic |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Net loss per share attributable to common stockholders, diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, basic |
||||||||||||||||
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, diluted |
||||||||||||||||
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Other comprehensive income (loss): |
||||||||||||||||
Foreign currency translation adjustments |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
|
|
|
|
|
|
|
|
Common Stock |
Additional Paid-in Capital |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Total Stockholders’ Equity | ||||||||||||||||||||
Shares |
Amount | |||||||||||||||||||||||
Balance as of June 30, 2021 |
$ | |
|
$ | $ | $ | ( |
) | $ | |||||||||||||||
Issuance of common stock from the exercise of stock options |
|
|
— | — | ||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock units (“RSUs”) |
|
|
( |
) | — | — | — | |||||||||||||||||
Stock-based compensation |
— | — | |
|
— | — | ||||||||||||||||||
Other comprehensive loss |
— | — | |
|
— | ( |
) | — | ( |
) | ||||||||||||||
Net loss |
— | — | |
|
— | — | ( |
) | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of September 30, 2021 |
$ | |
|
$ | $ | ( |
) | $ | ( |
) | $ | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
Additional Paid-in Capital |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Total Stockholders’ Equity | ||||||||||||||||||||
Shares |
Amount | |||||||||||||||||||||||
Balance as of December 31, 2020 |
$ | |
$ | $ | ( |
$ | ( |
) | $ | |||||||||||||||
Issuance of common stock from the exercise of stock options |
|
— | — | |||||||||||||||||||||
Issuance of common stock upon vesting of RSUs |
|
( |
) | — | — | — | ||||||||||||||||||
Issuance of common stock upon vesting of growth units |
|
( |
) | — | — | — | ||||||||||||||||||
Issuance of common stock upon net exercise of common stock warrants and other |
|
— | — | |||||||||||||||||||||
Stock-based compensation |
— | — | |
— | — | |||||||||||||||||||
Other comprehensive income |
— | — | |
— | — | |||||||||||||||||||
Net loss |
— | — | |
— | — | ( |
) | ( |
) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||
Balance as of September 30, 2021 |
$ | |
|
$ | |
$ | ( |
) | $ | ( |
) | $ | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Convertible Preferred Stock |
Convertible Preferred Stock |
Common Stock |
Additional Paid-in Capital |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
Total Stockholders’ Equity (Deficit) | ||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||
Balance as of June 30, 2020 |
$ | $ | $ | $ | $ | $ | ( |
$ | ( |
|||||||||||||||||||||||||||||||
Issuance of Series D preferred stock upon net exercise of Series D preferred stock warrants |
— |
— |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||
Issuance of common stock upon net exercise of common stock warrants |
— |
— |
— |
— |
( |
— |
— |
— |
||||||||||||||||||||||||||||||||
Issuance of common stock, net of issuance costs |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||||
Conversion of redeemable convertible preferred stock to common stock |
( |
( |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||||
Conversion of convertible preferred stock to common stock |
— |
— |
( |
( |
— |
— |
||||||||||||||||||||||||||||||||||
Conversion of preferred stock warrants to common stock warrants |
— |
— |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||
Issuance of common stock from the exercise of stock options |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock units |
— |
— |
— |
— |
( |
— |
— |
— |
||||||||||||||||||||||||||||||||
Stock-based compensation |
— |
— |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||
Settlement of employee loan accounted for as a modification to stock option |
— |
— |
— |
— |
( |
( |
( |
— |
— |
( |
||||||||||||||||||||||||||||||
Other comprehensive income |
— |
— |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||
Balance as of September 30, 2020 |
— |
$ | — |
— |
$ | — |
$ | $ | $ | $ | ( |
$ | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable Convertible Preferred Stock |
Convertible Preferred Stock |
Common Stock |
Additional Paid-in Capital |
Treasury Stock |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Total Stockholders’ Equity (Deficit) | |||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2019 |
$ | $ | $ | $ | $ | ( |
$ | ( |
$ | ( |
$ | ( |
||||||||||||||||||||||||||||||||||||
Conversion of Series H-1 convertible preferred stock to common stock |
— | — | ( |
( |
— | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Issuance of Series K convertible preferred stock |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Issuance of Series D preferred stock upon net exercise of Series D preferred stock warrants |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Repurchase of common stock, held in treasury |
— | — | — | — | ( |
— | — | ( |
— | — | ( |
|||||||||||||||||||||||||||||||||||||
Retirement of treasury stock |
— | — | — | — | — | ( |
( |
( |
— | — | — | |||||||||||||||||||||||||||||||||||||
Issuance of common stock upon net exercise of common stock warrants |
— | — | — | — | ( |
— | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Issuance of common stock, net of issuance costs |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Conversion of redeemable convertible preferred stock to common stock |
( |
( |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Conversion of convertible preferred stock to common stock |
— | — | ( |
( |
— | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Conversion of preferred stock warrants to common stock warrants |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Issuance of common stock from the exercise of stock options |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon vesting of RSUs |
— | — | — | — | ( |
— | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Settlement of employee loan accounted for as a modification to stock option |
— | — | — | — | ( |
( |
( |
— | — | — | — | ( |
||||||||||||||||||||||||||||||||||||
Other comprehensive income |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | — | — | ( |
( |
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||||||
Balance as of September 30, 2020 |
— | $ | — | — | $ | — | $ | $ | — | $ | — | $ | $ | ( |
$ | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, | ||||||||
2021 |
2020 | |||||||
Operating activities |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
||||||||
Depreciation and amortization |
||||||||
Stock-based compensation |
||||||||
Non-cash operating lease expense |
||||||||
Unrealized loss from marketable securities |
||||||||
Other operating activities |
||||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
( |
) | ( |
) | ||||
Prepaid expenses and other current assets |
( |
) | ( |
) | ||||
Other assets |
( |
) | ( |
) | ||||
Accounts payable |
( |
) | ||||||
Accrued liabilities |
||||||||
Deferred revenue, current and noncurrent |
( |
) | ( |
) | ||||
Customer deposits, current and noncurrent |
( |
) | ( |
) | ||||
Operating lease liabilities, current and noncurrent |
( |
) | ( |
) | ||||
Other noncurrent liabilities |
||||||||
|
|
|
|
|
| |||
Net cash provided by (used in) operating activities |
( |
) | ||||||
Investing activities |
||||||||
Purchases of property and equipment |
( |
) | ( |
) | ||||
Purchases of marketable securities |
( |
) | ||||||
Purchases of alternative investments |
( |
) | ||||||
Other investing activities |
( |
) | ( |
) | ||||
|
|
|
|
|
| |||
Net cash used in investing activities |
( |
) | ( |
) | ||||
Financing activities |
||||||||
Proceeds from the issuance of common stock, net of issuance costs |
||||||||
Proceeds from issuance of debt, net of issuance costs |
||||||||
Principal payments on borrowings |
( |
) | ( |
) | ||||
Proceeds from the exercise of common stock options |
||||||||
Repurchase of common stock |
( |
) | ||||||
Other financing activities |
( |
) | ( |
) | ||||
|
|
|
|
|
| |||
Net cash provided by financing activities |
||||||||
Effect of foreign exchange on cash, cash equivalents, and restricted cash |
( |
) | ( |
) | ||||
|
|
|
|
|
| |||
Net increase in cash, cash equivalents, and restricted cash |
||||||||
Cash, cash equivalents, and restricted cash - beginning of period |
||||||||
|
|
|
|
|
| |||
Cash, cash equivalents, and restricted cash - end of period |
$ | $ | ||||||
|
|
|
|
|
| |||
Supplemental disclosures of cash flow information: |
||||||||
Cash paid for income taxes |
$ | $ | ||||||
Cash paid for interest |
||||||||
Supplemental disclosures of non-cash investing and financing information: |
||||||||
Conversion of redeemable convertible and convertible preferred stock to common stock |
$ | $ | ||||||
Receivable from the exercise of common stock options included in prepaid expenses and other current assets |
||||||||
Conversion of convertible preferred stock warrants to common stock warrants |
||||||||
Cashless net exercise of warrants for convertible preferred stock |
As of September 30, | ||||||||
2021 |
2020 | |||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash |
||||||||
Restricted cash, noncurrent |
||||||||
|
|
|
|
|
| |||
Total cash, cash equivalents, and restricted cash |
$ | |
$ | |
||||
|
|
|
|
|
|
As of September 30, 2021 |
||||||||||||||||
Total |
Level 1 |
Level 2 |
Level 3 |
|||||||||||||
Assets: |
||||||||||||||||
Money market funds |
$ | $ | $ | — | $ | — | ||||||||||
Certificates of deposit |
— | — | ||||||||||||||
Marketable securities |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | $ | $ | $ | — | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
As of December 31, 2020 |
||||||||||||||||
Total |
Level 1 |
Level 2 |
Level 3 |
|||||||||||||
Assets: |
||||||||||||||||
Money market funds |
$ | $ | $ | — | $ | — | ||||||||||
Certificates of deposit |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | |
$ | $ | |
$ | — | |||||||||
|
|
|
|
|
|
|
|
Entity (1) |
Share Amount |
Investment Amount |
||||||||
Celularity |
|
$ | ||||||||
Faraday Future |
||||||||||
Astrocast |
||||||||||
BlackSky |
||||||||||
Lilium |
||||||||||
Roivant Sciences |
||||||||||
Sarcos Robotics |
||||||||||
Autonomous aerial vehicle company (2) |
||||||||||
|
|
|
|
|||||||
Total |
$ | |||||||||
|
|
|
|
(1) |
Investments are in publicly-traded marketable securities, unless otherwise noted. |
(2) |
Investment in privately-held company. |
As of September 30, 2021 |
As of December 31, 2020 | ||||||
Leasehold improvements |
$ | $ | |||||
Computer equipment, software, and other |
|||||||
Furniture and fixtures |
|||||||
Construction in progress |
|||||||
|
|
|
| ||||
Total property and equipment, gross |
|
| |||||
Less: accumulated depreciation and amortization |
( |
( | |||||
|
|
|
| ||||
Total property and equipment, net |
$ | $ | |||||
|
|
|
|
As of September 30, 2021 |
As of December 31, 2020 | ||||||
Accrued payroll and related expenses |
$ | $ | |||||
Accrued other liabilities |
|||||||
|
|
|
| ||||
Total accrued liabilities |
$ | |
$ | | |||
|
|
|
|
Entity |
Investment Agreement Date |
Committed Share Amount |
Committed Investment Amount | ||||||||
Mobility company (1) |
|
$ | |||||||||
Wejo |
|
||||||||||
Babylon Health (1) (2) |
|
||||||||||
Boxed ( 2 ) |
|
||||||||||
Pear Therapeutics |
|
||||||||||
Autonomous vehicle company ( 2 ) |
|
||||||||||
Fast Radius ( 2 ) |
|
||||||||||
Tritium ( 2 ) |
|
||||||||||
AdTheorent ( 2 ) |
|
||||||||||
FinAccel |
|
||||||||||
Energy Vault ( 2 ) |
|
||||||||||
Electric vehicle charging company ( 2 ) |
|
||||||||||
|
|
|
|
| |||||||
Total |
|
$ | |||||||||
|
|
|
|
|
(1) |
The Company’s investment closed after September 30, 2021. See further discussion in Note 14. Subsequent Events |
(2) |
Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed. |
As of September 30, 2021 |
As of December 31, 2020 |
|||||||||||||||
Authorized |
Issued and Outstanding |
Authorized |
Issued and Outstanding |
|||||||||||||
Common stock: |
||||||||||||||||
Class A |
||||||||||||||||
Class B |
||||||||||||||||
Class F |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Total |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
Weighted- Average Exercise Price Per Share |
Weighted- Average Remaining Contractual Life (years) |
Aggregate Intrinsic Value |
|||||||||||||
Balance as of December 31, 2020 |
$ | $ | ||||||||||||||
Options exercised |
( |
) | ||||||||||||||
Options canceled and forfeited |
( |
) | ||||||||||||||
|
|
|
||||||||||||||
Balance as of September 30, 2021 |
|
$ | $ | |||||||||||||
|
|
|
||||||||||||||
Options vested and exercisable as of September 30, 2021 |
$ | $ | ||||||||||||||
|
|
|
RSUs Outstanding |
Weighted Average Grant Date Fair Value per Share | |||||||
Unvested and outstanding as of December 31, 2020 |
$ | |||||||
RSUs granted |
||||||||
RSUs vested |
( |
) | ||||||
RSUs canceled |
( |
) | ||||||
|
|
|
||||||
Unvested and outstanding as of September 30, 2021 |
$ | |||||||
|
|
|
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Cost of revenue |
$ | $ | $ | $ | ||||||||||||
Sales and marketing |
||||||||||||||||
Research and development |
||||||||||||||||
General and administrative |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Total stock-based compensation expense (1) |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
On September 30, 2020, in connection with the Direct Listing, the Company incurred $ |
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Numerator |
||||||||||||||||
Net loss attributable to common stockholders |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Less: Change in fair value attributable to participating securities |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Net loss attributable to common stockholders, for diluted net loss per share |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Denominator |
||||||||||||||||
Weighted-average shares used in computing net loss per share, basic |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Weighted-average shares used in computing net loss per share, diluted |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Net loss per share |
||||||||||||||||
Net loss per share attributable to common stockholders, basic |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Net loss per share attributable to common stockholders, diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, | |||||||
2021 |
2020 | ||||||
Warrants to purchase common stock |
|||||||
Options and Stock Appreciation Rights issued and outstanding |
|||||||
RSUs outstanding |
|||||||
Growth units outstanding |
— | ||||||
|
|
|
|
| |||
Total |
|||||||
|
|
|
|
|
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Revenue: |
||||||||||||||||
Government |
$ | $ | $ | $ | ||||||||||||
Commercial |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Total revenue |
$ | $ | $ | $ | |
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Contribution: |
||||||||||||||||
Government |
$ | $ | $ | $ | ||||||||||||
Commercial |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Total contribution |
$ | $ | $ | |
$ | |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Loss from operations |
$ |
( |
$ |
( |
$ |
( |
$ |
( |
||||||||
Research and development expenses (1) |
||||||||||||||||
General and administrative expenses (1) |
||||||||||||||||
Stock-based compensation expense |
||||||||||||||||
Total contribution |
$ |
$ |
$ |
$ |
||||||||||||
Three Months Ended September 30, | ||||||||||||||||
2021 |
2020 | |||||||||||||||
Amount |
% |
Amount |
% | |||||||||||||
Revenue: |
||||||||||||||||
United States |
$ |
% |
$ |
% | ||||||||||||
United Kingdom |
% |
% | ||||||||||||||
Rest of world (1) |
% |
% | ||||||||||||||
Total revenue |
$ |
% |
$ |
% | ||||||||||||
Nine Months Ended September 30, | ||||||||||||||||
2021 |
2020 | |||||||||||||||
Amount |
% |
Amount |
% | |||||||||||||
Revenue: |
||||||||||||||||
United States |
$ |
% |
$ |
% | ||||||||||||
United Kingdom |
% |
% | ||||||||||||||
France |
% |
% | ||||||||||||||
Rest of world (1) |
% |
% | ||||||||||||||
Total revenue |
$ |
% |
$ |
% | ||||||||||||
Entity |
Investment Agreement Date |
Committed Share Amount |
Committed Investment Amount | ||||||
Telecommunications company (1) |
$ | ||||||||
Rigetti & Co, Inc. (1) |
|||||||||
Tota l |
$ | ||||||||
Entity |
Share Amount |
Investment Amount | |||||
Babylon Health (1) |
$ | ||||||
Mobility company (1) |
|||||||
Total |
$ | ||||||
• | our expectations regarding financial performance and liquidity, including but not limited to our expectations regarding revenue, cost of revenue, operating expenses, stock-based compensation, our ability to achieve and maintain future profitability, and cash flows; |
• | our ability to successfully execute our business and growth strategy; |
• | the sufficiency of our cash and cash equivalents to meet our liquidity needs; |
• | the demand for our platforms in general; |
• | our ability to increase our number of customers and revenue generated from customers; |
• | our expectations regarding the future contribution margin of our existing and future customers; |
• | our expectations regarding our ability to quickly and effectively integrate our platforms for our existing and future customers; |
• | our ability to develop new platforms, and enhancements to existing platforms, and bring them to market in a timely manner; |
• | our market share, category positions, and market trends, including our ability to grow our business in large government and commercial organizations, including our expectations regarding the impact of Federal Acquisition Streamlining Act of 1994 (“FASA”); |
• | our ability to compete with existing and new competitors in existing and new markets and products; |
• | our expectations regarding anticipated technology needs and developments and our ability to address those needs and developments with our platforms; |
• | our expectations regarding litigation and legal and regulatory matters; |
• | our expectations regarding our ability to meet existing performance obligations and maintain the operability of our products; |
• | our expectations regarding the effects of existing and developing laws and regulations, including with respect to taxation, privacy data protection, and cybersecurity; |
• | our expectations regarding new and evolving markets; |
• | our ability to develop and protect our brand; |
• | our ability to maintain the security and availability of our platforms; |
• | our expectations and management of future growth; |
• | our expectations concerning relationships with third parties, including our customers, equity method investment partners, and vendors; |
• | our expectations regarding our recent investments in, and enterprise agreements with, various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities; |
• | our ability to maintain, protect, and enhance our intellectual property; |
• | our expectations regarding our multi-class stock and governance structure and the benefits thereof; |
• | the impact of the ongoing COVID-19 pandemic, including on our and our customers’, vendors’, and partners’ respective businesses and the markets in which we and our customers, vendors, and partners operate; and |
• | the increased expenses associated with being a public company. |
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Loss from operations |
$ | (91,941 | ) | $ | (847,777 | ) | $ | (352,103 | ) | $ | (1,017,107 | ) | ||||
Add: |
||||||||||||||||
Research and development expenses (1) |
59,844 | 57,146 | 180,335 | 156,832 | ||||||||||||
General and administrative expenses (1) |
71,145 | 107,130 | 207,006 | 226,455 | ||||||||||||
Stock-based compensation |
184,835 | 846,959 | 611,308 | 1,028,914 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Contribution |
$ | 223,883 | $ | 163,458 | $ | 646,546 | $ | 395,094 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Contribution margin |
57 | % | 56 | % | 58 | % | 51 | % | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Gross profit |
$ | 305,342 | $ | 140,026 | $ | 857,181 | $ | 488,538 | ||||||||
Add: stock-based compensation |
14,860 | 94,385 | 54,866 | 120,285 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Gross profit, excluding stock-based compensation |
$ | 320,202 | $ | 234,411 | $ | 912,047 | $ | 608,823 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Gross margin, excluding stock-based compensation |
82 | % | 81 | % | 82 | % | 79 | % | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Loss from operations |
$ | (91,941 | ) | $ | (847,777 | ) | $ | (352,103 | ) | $ | (1,017,107 | ) | ||||
Add: stock-based compensation |
184,835 | 846,959 | 611,308 | 1,028,914 | ||||||||||||
Add: employer payroll taxes related to stock-based compensation |
23,215 | 20,172 | 90,214 | 20,172 | ||||||||||||
Add: non-recurring Direct Listing charges (1) |
— | 53,737 | — | 53,737 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Adjusted income from operations |
$ | 116,109 | $ | 73,091 | $ | 349,419 | $ | 85,716 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
• | Commercial non-government industries. |
• | Government non-U.S. governments. |
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Revenue |
$ | 392,146 | $ | 289,366 | $ | 1,109,022 | $ | 770,582 | ||||||||
Cost of revenue (1) |
86,804 | 149,340 | 251,841 | 282,044 | ||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Gross profit |
305,342 | 140,026 | 857,181 | 488,538 | ||||||||||||
Operating expenses: |
||||||||||||||||
Sales and marketing (1) |
153,443 | 334,911 | 451,919 | 536,082 | ||||||||||||
Research and development (1) |
94,316 | 313,915 | 303,311 | 466,530 | ||||||||||||
General and administrative (1) |
149,524 | 338,977 | 454,054 | 503,033 | ||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Total operating expenses |
397,283 | 987,803 | 1,209,284 | 1,505,645 | ||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Loss from operations |
(91,941) | (847,777) | (352,103) | (1,017,107) | ||||||||||||
Interest income |
379 | 494 | 1,127 | 4,312 | ||||||||||||
Interest expense |
(609) | (2,085) | (3,039) | (12,325) | ||||||||||||
Change in fair value of warrants |
— | (9,201) | — | 811 | ||||||||||||
Other income (expense), net |
(8,528) | (3,293) | (11,297) | 1,218 | ||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Loss before provision (benefit) for income taxes |
(100,699) | (861,862) | (365,312) | (1,023,091) | ||||||||||||
Provision (benefit) for income taxes |
1,438 | (8,543) | (1,121) | (5,043) | ||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Net loss |
$ | (102,137) | $ | (853,319) | $ | (364,191) | $ | (1,018,048) | ||||||||
|
|
|
|
|
|
|
|
|
(1) |
Includes stock-based compensation expense as follows (in thousands): |
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Cost of revenue |
$ | 14,860 | $ | 94,385 | $ | 54,866 | $ | 120,285 | ||||||||
Sales and marketing |
57,124 | 263,958 | 186,418 | 322,353 | ||||||||||||
Research and development |
34,472 | 256,769 | 122,976 | 309,698 | ||||||||||||
General and administrative |
78,379 | 231,847 | 247,048 | 276,578 | ||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Total stock-based compensation expense (i) |
$ | 184,835 | $ | 846,959 | $ | 611,308 | $ | 1,028,914 | ||||||||
|
|
|
|
|
|
|
|
|
(i) |
On September 30, 2020, in connection with the Direct Listing, we incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date. |
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 | |||||||||||||
Revenue |
100% |
100% |
100% |
100% |
||||||||||||
Cost of revenue |
22 |
52 |
23 |
37 |
||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Gross profit |
78 |
48 |
77 |
63 |
||||||||||||
Operating expenses: |
||||||||||||||||
Sales and marketing |
39 |
116 |
41 |
70 |
||||||||||||
Research and development |
24 |
108 |
27 |
61 |
||||||||||||
General and administrative |
38 |
117 |
41 |
64 |
||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Total operating expenses |
101 |
341 |
109 |
195 |
||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Loss from operations |
(23) |
(293) |
(32) |
(132) |
||||||||||||
Interest income |
— |
— |
— |
1 |
||||||||||||
Interest expense |
— |
(1) |
— |
(2) |
||||||||||||
Change in fair value of warrants |
— |
(3) |
— |
— |
||||||||||||
Other income (expense), net |
(3) |
(1) |
(1) |
— |
||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Loss before provision (benefit) for income taxes |
(26) |
(298) |
(33) |
(133) |
||||||||||||
Provision (benefit) for income taxes |
— |
(3) |
— |
(1) |
||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Net loss |
(26)% |
(295)% |
(33)% |
(132)% |
||||||||||||
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
Change |
|||||||||||||||
2021 |
2020 |
Amount |
% | |||||||||||||
Revenue: |
||||||||||||||||
Government |
$ |
217,836 |
$ |
162,561 |
$ |
55,275 |
34% |
|||||||||
Commercial |
174,310 |
126,805 |
47,505 |
37% |
||||||||||||
|
|
|
|
|
|
|||||||||||
Total revenue |
$ |
392,146 |
$ |
289,366 |
$ |
102,780 |
36% |
|||||||||
|
|
|
|
|
|
Three Months Ended September 30, |
Change |
|||||||||||||||
2021 |
2020 |
Amount |
% | |||||||||||||
Cost of revenue |
$ |
86,804 |
$ |
149,340 |
$ |
(62,536) |
(42)% |
|||||||||
Gross profit |
305,342 |
140,026 |
165,316 |
118% |
||||||||||||
Gross margin |
78% |
48% |
30% |
Three Months Ended September 30, |
Change |
|||||||||||||||
2021 |
2020 |
Amount |
% | |||||||||||||
Sales and marketing |
$ |
153,443 |
$ |
334,911 |
$ |
(181,468) |
(54)% |
|||||||||
Research and development |
94,316 |
313,915 |
(219,599) |
(70)% |
||||||||||||
General and administrative |
149,524 |
338,977 |
(189,453) |
(56)% |
||||||||||||
|
|
|
|
|
|
|
|
| ||||||||
Total operating expenses |
$ |
397,283 |
$ |
987,803 |
$ |
(590,520) |
(60)% |
|||||||||
|
|
|
|
|
|
Three Months Ended September 30, |
Change | |||||||||||
2021 |
2020 |
Amount | ||||||||||
Interest income |
$ |
379 |
$ |
494 |
$ |
(115) |
Three Months Ended September 30, |
Change | |||||||||||
2021 |
2020 |
Amount | ||||||||||
Interest expense |
$ | (609) | $ | (2,085) | $ | 1,476 |
Three Months Ended September 30, |
Change | |||||||||||
2021 |
2020 |
Amount | ||||||||||
Change in fair value of warrants |
$ | — | $ | (9,201) | $ | 9,201 |
Three Months Ended September 30, |
Change | |||||||||||
2021 |
2020 |
Amount | ||||||||||
Other income (expense), net |
$ | (8,528) | $ | (3,293) | $ | (5,235) |
Three Months Ended September 30, |
Change | |||||||||||
2021 |
2020 |
Amount | ||||||||||
Provision (benefit) for income taxes |
$ | 1,438 | $ | (8,543) | $ | 9,981 |
Nine Months Ended September 30, |
Change | |||||||||||||||
2021 |
2020 |
Amount |
% | |||||||||||||
Revenue: |
||||||||||||||||
Government |
$ | 658,375 | $ | 420,257 | $ | 238,118 | 57% | |||||||||
Commercial |
450,647 | 350,325 | 100,322 | 29% | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Total revenue |
$ | 1,109,022 | $ | 770,582 | $ | 338,440 | 44% | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
Change | |||||||||||||||
2021 |
2020 |
Amount |
% | |||||||||||||
Cost of revenue |
$ | 251,841 | $ | 282,044 | $ | (30,203 | ) | (11 | )% | |||||||
Gross profit |
857,181 | 488,538 | 368,643 | 75 | % | |||||||||||
Gross margin |
77 | % | 63 | % | 14 | % |
Nine Months Ended September 30, |
Change | |||||||||||||||
2021 |
2020 |
Amount |
% | |||||||||||||
Sales and marketing |
$ | 451,919 | $ | 536,082 | $ | (84,163) | (16 | )% | ||||||||
Research and development |
303,311 | 466,530 | (163,219) | (35 | )% | |||||||||||
General and administrative |
454,054 | 503,033 | (48,979) | (10 | )% | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Total operating expenses |
$ | 1,209,284 | $ | 1,505,645 | $ | (296,361) | (20 | )% | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
Change | |||||||||||
2021 |
2020 |
Amount | ||||||||||
Interest income |
$ | 1,127 | $ | 4,312 | $ | (3,185) |
Nine Months Ended September 30, |
Change | |||||||||||
2021 |
2020 |
Amount | ||||||||||
Interest expense |
$ | (3,039) | $ | (12,325) | $ | 9,286 |
Nine Months Ended September 30, |
Change | |||||||||||
2021 |
2020 |
Amount | ||||||||||
Change in fair value of warrants |
$ | — | $ | 811 | $ | (811) |
Nine Months Ended September 30, |
Change | |||||||||||
2021 |
2020 |
Amount | ||||||||||
Other income (expense), net |
$ | (11,297) | $ | 1,218 | $ | (12,515) |
Nine Months Ended September 30, |
Change | |||||||||||
2021 |
2020 |
Amount | ||||||||||
Benefit from income taxes |
$ | (1,121) | $ | (5,043) | $ | 3,922 |
Nine Months Ended September 30, |
||||||||
2021 |
2020 | |||||||
Net cash provided by (used in): |
||||||||
Operating activities |
$ | 240,424 | $ | (278,320) | ||||
Investing activities |
(216,039) | (9,975) | ||||||
Financing activities |
274,282 | 817,344 | ||||||
Effect of foreign exchange on cash, cash equivalents, and restricted cash |
(3,638) | (678) | ||||||
|
|
|
|
| ||||
Net increase in cash, cash equivalents, and restricted cash |
$ | 295,029 | $ | 528,371 | ||||
|
|
|
|
|
ITEM 1. |
LEGAL PROCEEDINGS |
ITEM 1A. |
RISK FACTORS |
• | we have incurred losses each year and we may not become profitable in the future; |
• | we may not be able to sustain our revenue growth rate; |
• | our sales efforts involve considerable time and expense and our sales cycle is often long and unpredictable; |
• | a limited number of customers account for a substantial portion of our revenue; |
• | our results of operations and our key business measures are likely to fluctuate significantly on a quarterly basis; |
• | seasonality may cause fluctuations in our results of operations and position; |
• | our platforms are complex and may have a lengthy implementation process; |
• | we may not successfully develop and deploy new technologies to address the needs of our customers; |
• | our platforms must operate with third-party products and services; |
• | we may be unable to hire, retain, train, and motivate qualified personnel and senior management and deploy our personnel and resources to meet customer demand; |
• | we may be unable to successfully build, expand, and deploy our marketing and sales organization; |
• | we may not be able to maintain and enhance our brand and reputation; |
• | unfavorable news or social media coverage may harm our reputation and business; |
• | exclusive arrangements or unique terms with customers or partners may result in significant risks or liabilities to us; |
• | we face intense competition in our markets; |
• | we may be unable to maintain or properly manage our culture as we grow; |
• | we may not enter into relationships with potential customers if we consider their activities to be inconsistent with our organizational mission or values; |
• | joint ventures, channel sales relationships, platform partners, and strategic alliances may be unsuccessful; |
• | we may not be successful in executing our strategy to increase our sales to larger customers; |
• | breach of the systems of any third parties upon which we rely, our customers’ cloud or on-premises environments, or our internal systems or unauthorized access to data; |
• | the COVID-19 pandemic may continue to significantly affect our business and operations; |
• | the market for our platforms and services may develop more slowly than we expect; |
• | we have made and may continue to make strategic investments to support key business initiatives, including in privately-held and publicly-traded companies as well as alternative investments, and we may not realize a return on these investments; |
• | issues raised by the use of artificial intelligence in our platforms may result in reputational harm or liability; |
• | we depend on computing infrastructure of third parties and they may experience errors, disruption, performance problems, or failure; |
• | we may fail to adequately obtain, maintain, protect, and enforce our intellectual property and other proprietary rights; |
• | we may be subject to intellectual property rights claims; |
• | there may be real or perceived errors, failures, defects, or bugs in our platforms; |
• | we rely on the availability of third-party technology that may be difficult to replace or that may cause errors; |
• | our business is subject to complex and evolving U.S. and non-U.S. laws and regulations regarding privacy, data protection and security, technology protection, and other matters; |
• | our non-U.S. sales and operations subject us to additional risks and regulations; |
• | we may encounter unfavorable outcomes in legal, regulatory, and administrative inquiries and proceedings; |
• | we may fail to receive and maintain government contracts or there may be changes in the contracting or fiscal policies of the public sector; |
• | the majority of our customer contracts may be terminated by the customer at any time for convenience and may contain other provisions permitting the customer to discontinue contract performance; |
• | we may not realize the full value of our customer contracts; |
• | there may be a decline in the U.S. and other government budgets, changes in spending or budgetary priorities, or delays in contract awards; and |
• | the multi-class structure of our common stock, the Founder Voting Trust Agreement, and the Founder Voting Agreement concentrate voting power with certain stockholders, in particular, our Founders and their affiliates. |
• | The success of our sales and marketing efforts, including the success of our pilot deployments; |
• | Our ability to increase our contribution margins and move our customers into the Expand or Scale phases; |
• | The timing of expenses and revenue recognition; |
• | The timing and amount of payments received from our customers; |
• | Termination of one or more large contracts by customers, including for convenience; |
• | The time and cost-intensive nature of our sales efforts and the length and variability of sales cycles; |
• | The amount and timing of operating expenses related to the maintenance and expansion of our business and operations; |
• | The timing and effectiveness of new sales and marketing initiatives; |
• | Changes in our pricing policies or those of our competitors; |
• | The timing and success of new products, features, and functionality introduced by us or our competitors; |
• | Interruptions or delays in our operations and maintenance (“O&M”) services; |
• | Cyberattacks and other actual or perceived data or security breaches; |
• | Our ability to hire and retain employees, in particular, those responsible for operations and maintenance of and the selling or marketing of our platforms, and develop and retain talented sales personnel who are able to achieve desired productivity levels in a reasonable period of time and provide sales leadership in areas in which we are expanding our sales and marketing efforts; |
• | The amount and timing of our stock-based compensation expenses; |
• | Changes in the way we organize and compensate our sales teams; |
• | Changes in the way we operate and maintain our platforms; |
• | Unforeseen negative results in operations from our partnerships, including those accounted for under the equity method; |
• | Changes in the competitive dynamics of our industry; |
• | The cost of and potential outcomes of existing and future claims or litigation, which could have a material adverse effect on our business; |
• | Changes in laws and regulations that impact our business, such as the Federal Acquisition Streamlining Act of 1994 (“FASA”); |
• | Indemnification payments to our customers or other third parties; |
• | Ability to scale our business with increasing demands; |
• | The timing of expenses related to any future acquisitions; and |
• | General economic, regulatory, and market conditions, including the impact of the COVID-19 pandemic. |
• | The fiscal year end procurement cycle of our government customers, and in particular U.S. government customers which have a fiscal year end of September 30; |
• | The fiscal year budgeting process for our commercial customers, many of which have a fiscal year end of December 31; |
• | Seasonal reductions in business activity during the summer months in the United States, Europe, and certain other regions; and |
• | Timing of projects and our customers’ evaluation of our work progress. |
• | Our failure to predict market demand accurately in terms of product functionality and to supply offerings that meet this demand in a timely fashion; |
• | Product defects, errors, or failures or our inability to satisfy customer service level requirements; |
• | Negative publicity or negative private statements about the security, performance, or effectiveness of our platforms or product enhancements; |
• | Delays in releasing to the market our new offerings or enhancements to our existing offerings, including new product modules; |
• | Introduction or anticipated introduction of competing platforms or functionalities by our competitors; |
• | Inability of our platforms or product enhancements to scale and perform to meet customer demands; |
• | Receiving qualified or adverse opinions in connection with security or penetration testing, certifications or audits, such as those related to IT controls and security standards and frameworks or compliance; |
• | Poor business conditions for our customers, causing them to delay software purchases; |
• | Reluctance of customers to purchase proprietary software products; |
• | Reluctance of our customers to purchase products hosted by our vendors and/or service interruption from such providers; and |
• | Reluctance of customers to purchase products incorporating open source software. |
• | cause certain customers to cease doing business with us; |
• | impair our ability to attract new customers, or to expand our relationships with existing customers; |
• | diminish our ability to recruit, hire, or retain employees; |
• | undermine our standing in professional communities to which we contribute and from which we receive expert knowledge; or |
• | prompt us to cease doing business with certain customers. |
• | Greater name recognition, longer operating histories, and larger customer bases; |
• | Larger sales and marketing budgets and resources and the capacity to leverage their sales efforts and marketing expenditures across a broader portfolio of products; |
• | Broader, deeper, or otherwise more established relationships with technology, channel and distribution partners, and customers; |
• | Wider geographic presence or greater access to larger potential customer bases; |
• | Greater focus in specific geographies; |
• | Lower labor and research and development costs; |
• | Larger and more mature intellectual property portfolios; and |
• | Substantially greater financial, technical, and other resources to provide services, to make acquisitions, and to develop and introduce new products and capabilities. |
• | Increased leverage held by large customers in negotiating contractual arrangements with us; |
• | Changes in key decision makers within these organizations that may negatively impact our ability to negotiate in the future; |
• | Customer IT departments may perceive that our platforms and services pose a threat to their internal control and advocate for legacy or internally developed solutions over our platforms; |
• | Resources may be spent on a potential customer that ultimately elects not to purchase our platforms and services; |
• | More stringent requirements in our service contracts, including stricter service response times, and increased penalties for any failure to meet service requirements; |
• | Increased competition from larger competitors, such as defense contractors, system integrators, or large software and service companies that traditionally target large enterprises and government entities and that may already have purchase commitments from those customers; and |
• | Less predictability in completing some of our sales than we do with smaller customers. |
• | Develop new products, features, capabilities, and enhancements; |
• | Continue to expand our product development, sales, and marketing organizations; |
• | Recruit, hire, train, and retain employees; |
• | Respond to competitive pressures or unanticipated working capital requirements; or |
• | Pursue acquisition or other growth or investment opportunities. |
• | Create liens on certain assets; |
• | Incur additional debt; |
• | Consolidate, merge, sell or otherwise dispose of all or substantially all of our assets; |
• | Sell certain assets; |
• | Pay dividends on or make distributions in respect of our capital stock; |
• | Place restrictions on certain activities of subsidiaries; |
• | Transact with our affiliates; and |
• | Use a portion of our cash resources. |
• | Any such transactions may negatively affect our financial results because it may require us to incur charges or assume substantial debt or other liabilities, may cause adverse tax consequences or unfavorable accounting treatment, may expose us to claims and disputes by third parties, including intellectual property claims and disputes, or may not generate sufficient financial return to offset additional costs and expenses related to the acquisition; |
• | Costs and potential difficulties associated with the requirement to test and assimilate the internal control processes of the acquired business; |
• | We may encounter difficulties or unforeseen expenditures assimilating or integrating the businesses, technologies, infrastructure, products, personnel, or operations of the acquired companies, particularly if the key personnel of the acquired company choose not to work for us or if we are unable to retain key personnel, if their technology is not easily adapted to work with ours, or if we have difficulty retaining the customers of any acquired business due to changes in ownership, management, or otherwise; |
• | We may not realize the expected benefits of the transactions; |
• | The transaction may disrupt our ongoing business, divert resources, increase our expenses, result in unfavorable public perception, and distract our management; |
• | An acquisition may result in a delay or reduction of customer purchases for both us and the company acquired due to customer uncertainty about continuity and effectiveness of service from either company; |
• | The potential impact on relationships with existing customers, vendors, and distributors as business partners; |
• | The potential that our due diligence of the applicable company or business does not identify significant problems or liabilities, or that we underestimate the costs and effects of identified liabilities; |
• | Exposure to litigation or other claims in connection with, or inheritance of claims or litigation risk as a result of, the transaction, including but not limited to claims from former employees, customers, or other third parties, which may differ from or be more significant than the risks our business faces; |
• | Potential goodwill impairment charges related to acquisitions; |
• | We may encounter difficulties in, or may be unable to, successfully sell any acquired products; |
• | The transaction may involve the entry into geographic or business markets in which we have little or no prior experience or where competitors have stronger market positions; |
• | An acquisition may require us to comply with additional laws and regulations, or to engage in substantial remediation efforts to cause the acquired company to comply with applicable laws or regulations, or result in liabilities resulting from the acquired company’s failure to comply with applicable laws or regulations; |
• | Our use of cash to pay for the transaction would limit other potential uses for our cash; |
• | If we incur debt to fund such a transaction, such debt may subject us to material restrictions on our ability to conduct our business as well as financial maintenance covenants; and |
• | To the extent that we issue a significant amount of equity securities in connection with such transactions, existing stockholders may be diluted and earnings per share may decrease. |
• | Increased management, travel, infrastructure, and legal and financial compliance costs and time associated with having multiple non-U.S. operations, including but not limited to compliance with local employment laws and other applicable laws and regulations; |
• | Longer payment cycles, greater difficulty in enforcing contracts, difficulties in collecting accounts receivable, especially in emerging markets, and the likelihood that revenue from non-U.S. system integrators, government contractors, and customers may need to be recognized when cash is received, at least until satisfactory payment history has been established, or upon confirmation of certain acceptance criteria or milestones; |
• | The need to adapt our platforms for non-U.S. customers whether to accommodate customer preferences or local law; |
• | Differing regulatory and legal requirements and possible enactment of additional regulations or restrictions on the use, import, or re-export of our platforms or the provision of services, which could delay, restrict, or prevent the sale or use of our platforms and services in some jurisdictions; |
• | Compliance with multiple and changing foreign laws and regulations, including those governing employment, privacy, data protection, information security, data transfer, and the risks and costs of non-compliance with such laws and regulations; |
• | New and different sources of competition not present in the United States; |
• | Heightened risks of unfair or corrupt business practices in certain geographies and of improper or fraudulent sales arrangements that may cause us to withdraw from particular markets, or impact financial results and result in restatements of financial statements and irregularities in financial statements; |
• | Volatility in non-U.S. political and economic environments, including by way of examples, the potential effects of COVID-19 and the United Kingdom’s departure from the European Union; |
• | Weaker protection of intellectual property rights in some countries and the risk of potential theft, copying, or other compromises of our technology, data, or intellectual property in connection with our non-U.S. operations, whether by state-sponsored malfeasance or other foreign entities or individuals; |
• | Volatility and fluctuations in currency exchange rates, including that, because many of our non-U.S. contracts are denominated in U.S. dollars, an increase in the strength of the U.S. dollar may make doing business with us less appealing to a non-U.S. dollar denominated customer; |
• | Management and employee communication and integration problems resulting from language differences, cultural differences, and geographic dispersion; |
• | Difficulties in repatriating or transferring funds from, or converting currencies in, certain countries; |
• | Potentially adverse tax consequences, including multiple and possibly overlapping tax regimes, the complexities of foreign value-added tax systems, and changes in tax laws; |
• | Lack of familiarity with local laws, customs, and practices, and laws and business practices favoring local competitors or partners; and |
• | Interruptions to our business operations and our customers’ business operations subject to events such as war, incidents of terrorism, natural disasters, public health concerns or epidemics (such as the COVID-19 pandemic), shortages or failures of power, internet, telecommunications, or hosting service providers, cyberattacks or malicious acts, or responses to these events. |
• | Changes in fiscal or contracting policies or decreases in available government funding; |
• | Changes in government programs or applicable requirements; |
• | Restrictions in the grant of personnel security clearances to our employees; |
• | Ability to maintain facility clearances required to perform on classified contracts for U.S. federal government and foreign government agencies; |
• | Changes in the political environment, including before or after a change to the leadership within the government administration, and any resulting uncertainty or changes in policy or priorities and resultant funding; |
• | Changes in the government’s attitude towards the capabilities that we offer, especially in the areas of national defense, cybersecurity, and critical infrastructure, including the financial, energy, telecommunications, and healthcare sectors; |
• | Changes in the government’s attitude towards us as a company or our platforms as viable or acceptable software solutions; |
• | Appeals, disputes, or litigation relating to government procurement, including but not limited to bid protests by unsuccessful bidders on potential or actual awards of contracts to us or our partners by the government; |
• | The adoption of new laws or regulations or changes to existing laws or regulations; |
• | Budgetary constraints, including automatic reductions as a result of “sequestration” or similar measures and constraints imposed by any lapses in appropriations for the federal government or certain of its departments and agencies; |
• | Influence by, or competition from, third parties with respect to pending, new, or existing contracts with government customers; |
• | Changes in political or social attitudes with respect to security or data privacy issues; |
• | Potential delays or changes in the government appropriations or procurement processes, including as a result of events such as war, incidents of terrorism, natural disasters, and public health concerns or epidemics, such as the coronavirus pandemic; and |
• | Increased or unexpected costs or unanticipated delays caused by other factors outside of our control, such as performance failures of our subcontractors. |
• | Terminate existing contracts for convenience with short notice; |
• | Reduce orders under or otherwise modify contracts; |
• | For contracts subject to the Truth in Negotiations Act, reduce the contract price or cost where it was increased because a contractor or subcontractor furnished cost or pricing data during negotiations that was not complete, accurate, and current; |
• | For some contracts, (i) demand a refund, make a forward price adjustment, or terminate a contract for default if a contractor provided inaccurate or incomplete data during the contract negotiation process and (ii) reduce the contract price under triggering circumstances, including the revision of price lists or other documents upon which the contract award was predicated; |
• | Cancel multi-year contracts and related orders if funds for contract performance for any subsequent year become unavailable; |
• | Decline to exercise an option to renew a multi-year contract or issue task orders in connection with indefinite delivery/indefinite quantity (“IDIQ”) contracts; |
• | Claim rights in solutions, systems, or technology produced by us, appropriate such work-product for their continued use without continuing to contract for our services, and disclose such work-product to third parties, including other government agencies and our competitors, which could harm our competitive position; |
• | Prohibit future procurement awards with a particular agency due to a finding of organizational conflicts of interest based upon prior related work performed for the agency that would give a contractor an unfair advantage over competing contractors, or the existence of conflicting roles that might bias a contractor’s judgment; |
• | Subject the award of contracts to protest by competitors, which may require the contracting federal agency or department to suspend our performance pending the outcome of the protest and may also result in a requirement to resubmit offers for the contract or in the termination, reduction, or modification of the awarded contract; |
• | Suspend or debar us from doing business with the applicable government; and |
• | Control or prohibit the export of our services. |
• | The number of shares of our Class A common stock publicly owned and available for trading; |
• | Price and volume fluctuations in the overall stock market from time to time; |
• | Volatility in the trading prices and trading volumes of technology stocks; |
• | Changes in operating performance and stock market valuations of other technology companies generally, or those in our industry in particular; |
• | Sales or expected sales of shares of our Class A common stock by us or our stockholders; |
• | Short-selling of our Class A common stock or related derivative securities; |
• | Failure of securities analysts to maintain coverage of us, changes in financial estimates by securities analysts who follow our company or our failure to meet these estimates or the expectations of investors; |
• | Any financial projections we may provide to the public, any changes in those projections or our failure to meet those projections; |
• | Announcements by us or our competitors of new services or platform features; |
• | The public’s reaction to our press releases, other public announcements, and filings with the SEC; |
• | Rumors and market speculation involving us or other companies in our industry; |
• | Actual or anticipated changes in our results of operations or fluctuations in our results of operations; |
• | Actual or anticipated developments in our business, our competitors’ businesses, or the competitive landscape generally; |
• | Litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors; |
• | Actual or perceived privacy or security breaches or other incidents; |
• | Developments or disputes concerning our intellectual property or other proprietary rights; |
• | Announced or completed acquisitions of businesses, services or technologies by us or our competitors; |
• | Changes in our management, including any departures of one of our Founders; |
• | New laws or regulations, public expectations regarding new laws or regulations or new interpretations of existing laws or regulations applicable to our business; |
• | Changes in accounting standards, policies, guidelines, interpretations, or principles; |
• | Any significant change in our management; |
• | Other events or factors, including those resulting from war, incidents of terrorism, pandemics, including the COVID-19 pandemic, or responses to these events; and |
• | General economic conditions and slow or negative growth of our markets. |
• | Our multi-class common stock structure, which provides our Founders and their affiliates with the ability to effectively control the outcome of matters requiring stockholder approval, even if they own significantly less than a majority of the shares of our outstanding common stock; |
• | Prior to the Final Class F Conversion Date (as defined in our amended and restated certificate of incorporation), the holders of our common stock will only be able to take action by written consent if the action also receives the affirmative consent of a majority of the outstanding shares of our Class F common stock, and after such point the holders of our common stock will only be able to take action at a meeting of the stockholders and will not be able to take action by written consent for any matter; |
• | From and after the Final Class F Conversion Date, our Board of Directors will be classified into three classes of directors with staggered three-year terms; |
• | Our amended and restated certificate of incorporation does not provide for cumulative voting; |
• | Vacancies on our Board of Directors will be able to be filled only by our Board of Directors and not by stockholders; |
• | Our directors may only be removed as provided in the Delaware General Corporation Law; |
• | A special meeting of our stockholders may only be called by the chairperson of our Board of Directors, our Chief Executive Officer, our President, or our Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directorships, whether or not there exist any vacancies or other unfilled seats in previously authorized directorships; |
• | Our amended and restated certificate of incorporation authorizes undesignated preferred stock, the terms of which may be established and shares of which may be issued without further action by our stockholders, except that any designation and issuance of preferred stock must receive the affirmative vote of a majority of the outstanding shares of our Class F common stock; and |
• | Advance notice procedures apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders. |
ITEM 2. |
UNREGISTERED SALES OF EQUITY SECURITIES |
ITEM 3. |
DEFAULTS UPON SENIOR SECURITIES |
ITEM 4. |
MINE SAFETY DISCLOSURES |
ITEM 5. |
OTHER INFORMATION |
ITEM 6. |
EXHIBITS |
Incorporated by Reference |
||||||||||||||||||
Exhibit Number |
Description |
Form |
File No. |
Exhibit |
Filing Date |
|||||||||||||
31.1* | ||||||||||||||||||
31.2* | ||||||||||||||||||
32.1† | ||||||||||||||||||
101.INS* | XBRL Instance Document. |
|||||||||||||||||
101.SCH* | XBRL Taxonomy Extension Schema Document. |
|||||||||||||||||
101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document. |
|||||||||||||||||
101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document. |
|||||||||||||||||
101.LAB* | XBRL Taxonomy Extension Label Linkbase Document. |
|||||||||||||||||
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document. |
* | Filed Herewith |
† | The certifications attached as Exhibit 32.1 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing. |
PALANTIR TECHNOLOGIES INC. | ||||||
Date: November 9, 2021 |
By: |
/s/ Alexander C. Karp | ||||
Alexander C. Karp | ||||||
Chief Executive Officer | ||||||
( Principal Executive Officer | ||||||
Date: November 9, 2021 |
By: |
/s/ David Glazer | ||||
David Glazer | ||||||
Chief Financial Officer | ||||||
( Principal Financial Officer | ||||||
Date: November 9, 2021 |
By: |
/s/ Jeffrey Buckley | ||||
Jeffrey Buckley | ||||||
Chief Accounting Officer | ||||||
( Principal Accounting Officer |